A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation
Open Access
- 19 August 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (33), 11605-11612
- https://doi.org/10.1073/pnas.0801182105
Abstract
Sulfation is an important biological process that modulates the function of numerous molecules. It is directly mediated by cytosolic and Golgi sulfotransferases, which use 3′-phosphoadenosine 5′-phosphosulfate to produce sulfated acceptors and 3′-phosphoadenosine 5′-phosphate (PAP). Here, we identify a Golgi-resident PAP 3′-phosphatase (gPAPP) and demonstrate that its activity is potently inhibited by lithium in vitro. The inactivation of gPAPP in mice led to neonatal lethality, lung abnormalities resembling atelectasis, and dwarfism characterized by aberrant cartilage morphology. The phenotypic similarities of gPAPP mutant mice to chondrodysplastic models harboring mutations within components of the sulfation pathway lead to the discovery of undersulfated chondroitin in the absence of functional enzyme. Additionally, we observed loss of gPAPP leads to perturbations in the levels of heparan sulfate species in lung tissue and whole embryos. Our data are consistent with a model that clearance of the nucleotide product of sulfotransferases within the Golgi plays an important role in glycosaminoglycan sulfation, provide a unique genetic basis for chondrodysplasia, and define a function for gPAPP in the formation of skeletal elements derived through endochondral ossification.Keywords
This publication has 58 references indexed in Scilit:
- JAWS coordinates chondrogenesis and synovial joint positioningDevelopment, 2008
- Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family membersJCI Insight, 2007
- Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesisDevelopment, 2005
- Alteration of Lithium Pharmacology through Manipulation of Phosphoadenosine Phosphate MetabolismPublished by Elsevier BV ,2005
- A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotypeHuman Molecular Genetics, 2005
- The evolving definition of a chondrodysplasia?Pediatric Pathology & Molecular Medicine, 2003
- The evolving definition of a chondrodysplasia?Pediatric Pathology & Molecular Medicine, 2003
- Kinetics of PAPS Translocase: Evidence for an Antiport MechanismBiochemistry, 1996
- Inhibition of M and P Phenol Sulfotransferase by Analogues of 3′‐Phosphoadenosine‐5′‐PhosphosulfateJournal of Neurochemistry, 1987
- The Effects of Lithium on myo‐Inositol Levels in Layers of Frontal Cerebral Cortex, in Cerebellum, and in Corpus Callosum of the RatJournal of Neurochemistry, 1980